Status:
COMPLETED
Remotely Controlled Intervention for Developmental Reading and Spelling Disorders Through the Tachidino Platform
Lead Sponsor:
IRCCS Eugenio Medea
Conditions:
Developmental Dyslexia
Developmental Spelling Disorder
Eligibility:
All Genders
7-16 years
Brief Summary
The study aims to document the effects of the intervention system for specific reading and spelling disorders, currently in use at Scientific Institute (IRCCS) Medea as an innovative intervention mode...
Detailed Description
The system for the improvement of reading and writing skills ("Tachidino" software) is based on two principles of proven effectiveness: 1. The selective stimulation of a cerebral hemisphere and speci...
Eligibility Criteria
Inclusion
- A formal diagnosis of Developmental Dyslexia, Specific Reading Disorders, Specific Spelling Disorders or Mixed Learning Disorders
- Age between 7 and 16
- Attending at least the third class of primary school
- Monolingual speakers of Italian or bilingual speakers with perfect mastery of the Italian language (equivalent to monolinguals)
- Intelligence Quotient (IQ) \>= 80
- At least one z-score below -2 Standard Deviations from age mean in at least one of the following tests: text reading, word reading, nonword reading, word writing to dictation, nonword writing to dictation ("DDE-2" battery, "MT" tests)
- Not having received any specific rehabilitation treatment for dyslexia before
Exclusion
- Intellectual disability
- Neurological disorders
- Sensory deficits that are not /cannot be corrected-to-normal by lenses or hearing aids.
Key Trial Info
Start Date :
January 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04382482
Start Date
January 20 2018
End Date
January 30 2021
Last Update
March 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scientific Institute IRCCS E. Medea
Bosisio Parini, LC, Italy, 23842